1.Expression status of HER2 in mammary and extramammary Paget's disease.
Hui MENG ; Xiang-Yu ZHENG ; Lan ZHANG ; Wen-Cai LI
Chinese Journal of Pathology 2011;40(4):255-256
Adult
;
Aged
;
Breast Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
;
Female
;
Gene Amplification
;
Genital Neoplasms, Male
;
genetics
;
metabolism
;
pathology
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Paget Disease, Extramammary
;
genetics
;
metabolism
;
pathology
;
surgery
;
Paget's Disease, Mammary
;
genetics
;
metabolism
;
pathology
;
surgery
;
Penile Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
;
Receptor, ErbB-2
;
genetics
;
metabolism
;
Scrotum
;
Vulvar Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
2.The role of anti-annexin A2 antibodies in antiphospholipid syndrome
Wen AO ; Hui ZHENG ; Xiaowei CHEN ; Yon SHEN ; Chengde YANG
Chinese Journal of Rheumatology 2009;13(6):364-367
Objective This study has explored the role of antibody against annexin A2 in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Methods Using purified recombinant annexin A2, IgG anti-annexin A2 antibody was measured by ELISA in 101 APS patients, 41 SLE patients with thrombosis, 124 SLE patients without thrombosis and 120 healthy controls. Results The positive rate of IgG anti-annexin A2 antibody in APS patients and SLE patients with thrombosis was 21.8%, 26.8%, respectively, they were all significantly higher than in SLE patients without thrombosis (6.5%). IgG anti-annexin A2 antibody was associated with thrombosis and/or pregnancy morbidity (P<0.01). Conclusion Anti-annexin A2 antibody is associated with thrombosis and/or pregnancy mnrbidity. It suggests that anti-annexin A2 antibody may be helpful in identifying in some potential AIRS.
3.Pathologic features of BRCA-associated ovarian carcinoma.
Chinese Journal of Pathology 2013;42(12):846-850
Age of Onset
;
Cystadenocarcinoma, Serous
;
genetics
;
metabolism
;
pathology
;
Female
;
Genes, BRCA1
;
Genes, BRCA2
;
Humans
;
Immunohistochemistry
;
Neoplasm Staging
;
Ovarian Neoplasms
;
genetics
;
metabolism
;
pathology
;
Receptors, Progesterone
;
metabolism
;
Tumor Suppressor Protein p53
;
metabolism
4.Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features.
Chinese Journal of Pathology 2013;42(9):624-628
Adenocarcinoma, Clear Cell
;
metabolism
;
pathology
;
Adenocarcinoma, Mucinous
;
metabolism
;
pathology
;
Carcinoma, Endometrioid
;
metabolism
;
pathology
;
Carcinoma, Transitional Cell
;
metabolism
;
pathology
;
Cystadenocarcinoma, Serous
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Neoplasms, Glandular and Epithelial
;
classification
;
metabolism
;
pathology
;
Ovarian Neoplasms
;
classification
;
metabolism
;
pathology
;
Tumor Suppressor Protein p53
;
metabolism
;
WT1 Proteins
;
metabolism
5.Exploration and characteristics of immunological paper free examination system
Fengping SHAN ; Changlong LV ; Hui FENG ; Li ZHENG ; Deliang WEN
Chinese Journal of Medical Education Research 2013;(1):42-43
Education reform and innovative education are the strong requirements of the times and social development.We developed immunological paper free examination system based on the optimized question bank,characteristics of immunological examination and information technology.This system can randomly develop electronic examination paper and can integrate the processes of exam registration,examination paper development,online examination,paper inspection,scores generation and printing into one system,which can save human resources,enhance the accuracy and fairness of the examination,making it conform to international standards.
6.Neoadjuvant chemotherapy's value and significance in combining with surgical treatment for limited small cell lung cancer (LD-SCLC)
Yongjie XU ; Hui ZHENG ; Gening JIANG ; Chang CHEN ; Wen GAO
Chinese Journal of Thoracic and Cardiovascular Surgery 2014;30(8):473-475
Objective To analyze and evaluate neoadjuvant chemotherapy's value and significance in combining with surgical treatment for limited small cell lung cancer(LD-SCLC).Methods A total of 94 LD-SCLC patients underwent complete resections combined with chemotherapy between January 2000 and January 2011 in Shanghai Pulmonary Hospital.Among these cases,initial two cycles of neoadjuvant chemotherapies were performed for all pathologically confirmed patients (Group A),and initial operations followed by adjuvant chemotherapy were administered to patients without pathology (Group B).The survival rate was analyzed by log-rank test and Kaplan-Meier method.Multivariate analysis of the prognostic factors was performed using Cox's regression model.Results Group A included 43 cases and Group B included 51 cases.The mean age was (56.37 ± 10.18) years.According to the 6th edition of Tumor,Node,Metastasis(TNM) classification of lung cancer,54 cases were at stage Ⅰ or Ⅱ,40 cases were at stage Ⅲ.Overall 5-year survival(5-YS) was 27%.The 5-YS for patients with stage Ⅰ-Ⅱ was notably better than that of stage Ⅲ (34% vs 20%,P =0.033).For patients with stage Ⅲ,the 5-YS of Group A was significantly better than that of Group B(34% vs 12%,P =0.020),besides median overall survival for Group A and Group B were 46 and 15 months(P =0.009).Furthermore,the results of multivariate analysis showed that neoadjuvant chemotherapy,surgery and histopathology of SCLC were independent factors that strongly affected survival and prognosis.Conclusion In combined surgical treatment for LD-SCLC,neoadjuvant chemotherapy obviously improved the prognosis of patients with stage Ⅲ.Therefore,it was very important and necessary that pre-surgical neoadjuvant chemotherapy was administered to resectable stage Ⅲ LD-SCLC patients.
7.Comparison between the New and Old Diagnostic Criteria of Neonatal Systemic Inflammatory Response Syndrome in Neonatal Septic Shock
xiao-wen, CHEN ; ke-zheng, CHEN ; hui, LV ; li, TAO
Journal of Applied Clinical Pediatrics 2006;0(13):-
0.05).Conclusions Neither the new nor old SIRS diagnostic criteria had a high conforning rate with neonatal critical illnesses;There was no significant difference between them in each clinical item.It shows that the new SIRS diagnostic criteria is not superior to the old one,therefore we should improve the neonatal SIRS diagnostic criteria in the future.
8.A case report of lead encephalopathy.
Hui-ping WANG ; Shu-fang ZHENG ; Ying-wen ZHENG ; Shi-tong SHI ; Jing-yan LIU
Chinese Journal of Pediatrics 2003;41(2):118-118
10.A high throughput coupled with high performance liquid chromatography-tandem mass spectrometry method for determination of aflatoxin B1, B2, G1, G2 in 10 traditional Chinese medicines.
Run-Sheng ZHENG ; Hui XU ; Yuan-Xia PENG ; Wen-Li WANG ; Ruo-Ting ZHAN ; Wei-Wen CHEN
China Journal of Chinese Materia Medica 2014;39(2):273-277
As the dilution procedure was applied, a simple, rapid and cost-effective high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of aflatoxin B1, B2, G1, and G2 was successfully by performed in a total 83 samples of 10 traditional Chinese medicines (TCMs), which were collected from 5 different hospital pharmacies and 5 different medical stores in Guangzhou city. Matrix effects of these 10 TCMs were ranged from 80.23% to 115.5% in low, intermediate and high concentration levels, indicating that the negative effect was overcome in this study. Meanwhile, the analysis method was proved to be stable and reliable during the whole analysis using Semen Armeniacae Amarum spiked 3 concentration levels of standard solution as quality control samples and the RSD < 6.6% was obtained. The contamination levels of 83 investigated samples were 13.89% and 17.02% in hospital pharmacies and medical stores, respectively. The result was presented to provide relevant reference and supplement to those researchers in TCMs analysis and screening.
Aflatoxin B1
;
analysis
;
Aflatoxins
;
analysis
;
Chromatography, High Pressure Liquid
;
methods
;
Drug Contamination
;
Medicine, Chinese Traditional
;
Quality Control
;
Tandem Mass Spectrometry
;
methods